Bright Health Group, Inc., an integrated care delivery company, engages in the delivery and financing of health insurance plans in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The company offers individual and family, Medicare, and employers insurance plans. It also operates 28 managed and affiliated risk-bearing primary care clinics. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is based in Minneapolis, Minnesota.
IPO Year: 2021
Exchange: NYSE
Website: brighthealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2022 | Neutral → Underweight | JP Morgan | |
| 3/29/2022 | Overweight → Neutral | JP Morgan | |
| 3/4/2022 | $9.00 → $3.00 | Outperform → Sector Perform | RBC Capital |
| 3/3/2022 | $4.00 → $2.00 | Underweight | Morgan Stanley |
| 3/3/2022 | $5.00 → $3.50 | Neutral | Goldman Sachs |
| 3/3/2022 | $5.50 → $4.00 | Overweight | Barclays |
| 3/3/2022 | $10.00 → $5.00 | Overweight | Piper Sandler |
| 3/2/2022 | Buy → Underperform | BofA Securities | |
| 1/10/2022 | $5.00 → $3.50 | Neutral | Citigroup |
| 1/7/2022 | $9.00 → $5.50 | Overweight | Barclays |
SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)
SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)
SC 13D - Bright Health Group Inc. (0001671284) (Subject)
JP Morgan downgraded Bright Health Group from Neutral to Underweight
JP Morgan downgraded Bright Health Group from Overweight to Neutral
RBC Capital downgraded Bright Health Gr from Outperform to Sector Perform and set a new price target of $3.00 from $9.00 previously
Morgan Stanley reiterated coverage of Bright Health Gr with a rating of Underweight and set a new price target of $2.00 from $4.00 previously
Goldman Sachs reiterated coverage of Bright Health Gr with a rating of Neutral and set a new price target of $3.50 from $5.00 previously
Barclays reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $4.00 from $5.50 previously
Piper Sandler reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $5.00 from $10.00 previously
BofA Securities downgraded Bright Health Group from Buy to Underperform
Citigroup resumed coverage of Bright Health Group with a rating of Neutral and set a new price target of $3.50 from $5.00 previously
Barclays reiterated coverage of Bright Health Gr with a rating of Overweight and set a new price target of $5.50 from $9.00 previously
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
4 - Bright Health Group Inc. (0001671284) (Issuer)
Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible
Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi
Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi
Company seeks to unlock the power of nature's sweet plant proteins; Wing brings broad expertise across consumer-focused industries as a founder and growth leader focused on healthy living Joywell Foods, a food technology and consumer goods company specializing in sweet plant proteins, announces the appointment of Ali Wing as Chief Executive Officer who joined earlier this year. Wing comes to Joywell as an experienced growth leader. Most recently, Wing served as the chief consumer officer of a healthcare technology company, Bright Health (NYSE:BHG). Prior to Bright Health, Ali's career has spanned consumer goods, retail and technology as a brand leader at companies including giggle and NIK
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
10-Q - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K - Bright Health Group Inc. (0001671284) (Filer)
8-K/A - Bright Health Group Inc. (0001671284) (Filer)
The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock
Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar
Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final
The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document. Medical Home Network (MHN) provider partners participating in NeueHealth Premier ACO achieved $10.1 million in gross savings and a 100% quality score in the 2022 performance year, according to data recently released from the Centers for Medicare and Medicaid Services (CMS). These results were achieved under the Global and Professional Direct Contracting Model, now known as the ACO Realizing Equity, Access, and Community Health (REACH) Mode
Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe
Medical claims runout is estimated to be over 98% complete and continues to track with prior forecasts Completed payments to fully satisfy risk adjustment obligations in seven states Enters into repayment agreements with CMS and four states to fully satisfy all remaining risk adjustment obligations over the next 18 months Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it continues to make progress on the wind-down of its ACA insurance business. The Company has made significant progress paying down its medical claims obligations and is on track with prior forecasts. As of the end of
Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi
Enters $60 million credit facility with NEA Announces entering permanent waiver of default on existing credit facility Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into a credit facility with an investment partnership of New Enterprise Associates ("NEA") with $60 million of credit capacity on August 4, 2023. Bright Health is also announcing that it has entered into a permanent waiver of default on its existing credit facility, which expires in February 2024. Mike Mikan, President and CEO of Bright Health, said, "We are excited to have the continued support of NEA, an
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accesse
Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe
Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi
Enters $60 million credit facility with NEA Announces entering permanent waiver of default on existing credit facility Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into a credit facility with an investment partnership of New Enterprise Associates ("NEA") with $60 million of credit capacity on August 4, 2023. Bright Health is also announcing that it has entered into a permanent waiver of default on its existing credit facility, which expires in February 2024. Mike Mikan, President and CEO of Bright Health, said, "We are excited to have the continued support of NEA, an
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accesse
Q1'23 Revenue from Continuing Business of $756.3 million, up 23% year over year on strong growth in Consumer Care external value-based consumers served Q1'23 Net Loss from Continuing Business of $94.8 million, Adjusted EBITDA Loss of $35.1 million Consumer Care segment generated positive Operating Income in Q1'23 Q1'23 California MCR was 89.0% excluding prior period Medical Costs, consistent with seasonal expectations Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clin
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday, May 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 1, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed v
Bright Health Group, Inc. ("Bright Health") (NYSE:BHG) today announced it will report Third Quarter financial results before the financial markets open on Wednesday, November 9, 2022, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthealthgroup.com. The company suggests participants for the c
Reaffirms previous 2022 Adjusted EBITDA guidance at midpoint and accelerates Adjusted EBITDA profitability to 2023, a year earlier than previously anticipated Will no longer offer Individual and Family Plan products through Bright HealthCare in 2023, or Medicare Advantage products outside of California and Florida Raises $175 million of committed convertible preferred equity capital to fully fund business to profitability Expects to deliver a $3 billion Net Revenue balanced business in 2023 through its risk-bearing care delivery and Medicare Advantage businesses Bright Health Group, Inc. ("Bright Health") (NYSE:BHG) today announced its decision to further focus its business on its